161 related articles for article (PubMed ID: 33076604)
21. A gap analysis of SDG 3 and MDG 4/5mortality health targets in the six Arabic countries of North Africa: Egypt, Libya, Tunisia, Algeria, Morocco, and Mauritania.
Bjegovic-Mikanovic V; Abousbie ZAS; Breckenkamp J; Wenzel H; Broniatowski R; Nelson C; Vukovic D; Laaser U
Libyan J Med; 2019 Dec; 14(1):1607698. PubMed ID: 31032713
[TBL] [Abstract][Full Text] [Related]
22. Assessing the potential outcomes of achieving the World Health Organization global non-communicable diseases targets for risk factors by 2025: is there also an economic dividend?
Devaux M; Lerouge A; Ventelou B; Goryakin Y; Feigl A; Vuik S; Cecchini M
Public Health; 2019 Apr; 169():173-179. PubMed ID: 30876722
[TBL] [Abstract][Full Text] [Related]
23. Progress and challenges in achieving noncommunicable diseases targets for the sustainable development goals.
Singh Thakur J; Nangia R; Singh S
FASEB Bioadv; 2021 Aug; 3(8):563-568. PubMed ID: 34377953
[TBL] [Abstract][Full Text] [Related]
24. Implications of the growing burden of diabetes for premature cardiovascular disease mortality and the attainment of the Sustainable Development Goal target 3.4.
Wou C; Unwin N; Huang Y; Roglic G
Cardiovasc Diagn Ther; 2019 Apr; 9(2):140-149. PubMed ID: 31143635
[TBL] [Abstract][Full Text] [Related]
25. Increased Mortality Trends in Patients With Chronic Non-communicable Diseases and Comorbid Hypertension in the United States, 2000-2019.
Ouyang F; Cheng X; Zhou W; He J; Xiao S
Front Public Health; 2022; 10():753861. PubMed ID: 35899158
[TBL] [Abstract][Full Text] [Related]
26. Burden of non-communicable diseases and the achievement of the sustainable development goals in 2030 in Mercosur countries.
Malta DC; Gomes CS; Veloso GA; Dias de Andrade FM; Souza JB; Freitas PC; Vasconcelhos de Oliveira PP; Naghavi M; Pinho Ribeiro AL
Public Health; 2023 Oct; 223():162-170. PubMed ID: 37659322
[TBL] [Abstract][Full Text] [Related]
27. [Predictions of achievement of Sustainable Development Goal to reduce age-standardized mortality rate of four major non-communicable diseases by 2030 in China].
Xu QQ; Yan YF; Chen H; Dong WL; Han LY; Liu S
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Jun; 43(6):878-884. PubMed ID: 35725345
[No Abstract] [Full Text] [Related]
28. Increase in premature mortality due to non-communicable diseases in Sri Lanka during the first decade of the twenty-first century.
Ediriweera DS; Karunapema P; Pathmeswaran A; Arnold M
BMC Public Health; 2018 May; 18(1):584. PubMed ID: 29720157
[TBL] [Abstract][Full Text] [Related]
29. Integrated management of non-communicable diseases in low-income settings: palliative care, primary care and community health synergies.
Munday D; Kanth V; Khristi S; Grant L
BMJ Support Palliat Care; 2019 Dec; 9(4):e32. PubMed ID: 30389694
[TBL] [Abstract][Full Text] [Related]
30. National, regional, and global levels and trends in neonatal mortality between 1990 and 2017, with scenario-based projections to 2030: a systematic analysis.
Hug L; Alexander M; You D; Alkema L;
Lancet Glob Health; 2019 Jun; 7(6):e710-e720. PubMed ID: 31097275
[TBL] [Abstract][Full Text] [Related]
31. Burden of premature mortality caused by four main non-communicable diseases in Ukraine.
Ryngach NO; Vlasyk LY
Wiad Lek; 2018; 71(3 pt 2):728-732. PubMed ID: 29783257
[TBL] [Abstract][Full Text] [Related]
32. Reducing Premature Mortality from Cardiovascular and Other Non-Communicable Diseases by One Third: Achieving Sustainable Development Goal Indicator 3.4.1.
Frieden TR; Cobb LK; Leidig RC; Mehta S; Kass D
Glob Heart; 2020 Jul; 15(1):50. PubMed ID: 32923344
[TBL] [Abstract][Full Text] [Related]
33. Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services.
Bertram MY; Sweeny K; Lauer JA; Chisholm D; Sheehan P; Rasmussen B; Upreti SR; Dixit LP; George K; Deane S
Lancet; 2018 May; 391(10134):2071-2078. PubMed ID: 29627159
[TBL] [Abstract][Full Text] [Related]
34. The Global Burden of Disease Study and the Preventable Burden of NCD.
Benziger CP; Roth GA; Moran AE
Glob Heart; 2016 Dec; 11(4):393-397. PubMed ID: 27938824
[TBL] [Abstract][Full Text] [Related]
35. Incorporating neglected non-communicable diseases into the national health program-A review.
Bhattacharya S; Heidler P; Varshney S
Front Public Health; 2022; 10():1093170. PubMed ID: 36703821
[TBL] [Abstract][Full Text] [Related]
36. Implementation of non-communicable disease policies: a geopolitical analysis of 151 countries.
Allen LN; Nicholson BD; Yeung BYT; Goiana-da-Silva F
Lancet Glob Health; 2020 Jan; 8(1):e50-e58. PubMed ID: 31813787
[TBL] [Abstract][Full Text] [Related]
37. Translating the WHO 25×25 goals into a UK context: the PROMISE modelling study.
Cobiac LJ; Scarborough P
BMJ Open; 2017 Apr; 7(4):e012805. PubMed ID: 28377390
[TBL] [Abstract][Full Text] [Related]
38. A path to cooperation between China and Mongolia towards the control of echinococcosis under the Belt and Road Initiative.
Qian YJ; Ding W; Wu WP; Bandikhuu A; Damdindorj T; Nyamdorj T; Bold B; Dorjsuren T; Sumiya G; Guan YY; Zhou XN; Li SZ; Don Eliseo LP
Acta Trop; 2019 Jul; 195():62-67. PubMed ID: 31009597
[TBL] [Abstract][Full Text] [Related]
39. Achieving a 25% reduction in premature non-communicable disease mortality: the Swedish population as a cohort study.
Santosa A; Rocklöv J; Högberg U; Byass P
BMC Med; 2015 Mar; 13():65. PubMed ID: 25889300
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
